Table 1

Relationship of HER-2/neu overexpression and clinicopathological parameters in prostate cancer (n = 83) and hormone naïve prostate cancer (n = 45)

Prostate cancer
 Path stage
 Pretreatment PSA
 Ki index
 Hormone status
Hormone naïve prostate cancer
 Gleason score
 Path stage
 Pretreatment PSA
 Ki index
  • a P generated from the Wald test using SAS procedure LOGISTIC where PSA is a continuous variable.